Diepen Sv, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary management of cardiogenic shock: A scientific statement from the American heart association. Circulation. 2017;136(16):e232–68.

Google Scholar 

Samsky MD, Morrow DA, Proudfoot AG, Hochman JS, Thiele H, Rao SV. Cardiogenic shock after acute myocardial infarction: A review. JAMA. 2021;326(18):1840–50.

Article  PubMed  PubMed Central  Google Scholar 

Jentzer JC. Understanding Cardiogenic Shock Severity and Mortality Risk Assessment. Circulation: Heart Failure. 2020;13(9):e007568.

Møller JE, Engstrøm T, Jensen LO, Eiskjær H, Mangner N, Polzin A, et al. Microaxial flow pump or standard care in Infarct-Related cardiogenic shock. N Engl J Med. 2024;390(15):1382–93.

Article  PubMed  Google Scholar 

Thiele H, Zeymer U, Akin I, Behnes M, Rassaf T, Mahabadi AA, et al. Extracorporeal life support in Infarct-Related cardiogenic shock. N Engl J Med. 2023;389(14):1286–97.

Article  PubMed  CAS  Google Scholar 

Sinha SS, Morrow DA, Kapur NK, Kataria R, Roswell RO. 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Evaluation and Management of Cardiogenic Shock. JACC. 2025;85(16):1618-41.

Hochman JS. Cardiogenic shock complicating acute myocardial infarction. Circulation. 2003;107(24):2998–3002.

Article  PubMed  Google Scholar 

Silvis MJM, Kaffka Genaamd Dengler SE, Odille CA, Mishra M, van der Kaaij NP, Doevendans PA, et al. Damage-Associated molecular patterns in myocardial infarction and heart transplantation: the road to translational success. Front Immunol. 2020;11:599511.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Prondzinsky R, Unverzagt S, Lemm H, Wegener NA, Schlitt A, Heinroth KM, et al. Interleukin-6, -7, -8 and– 10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. Clin Res Cardiol. 2012;101(5):375–84.

Article  PubMed  CAS  Google Scholar 

Geppert A, Dorninger A, Delle-Karth G, Zorn G, Heinz G, Huber K. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction. Crit Care Med. 2006;34(8):2035–42.

Article  PubMed  CAS  Google Scholar 

Debrunner M, Schuiki E, Minder E, Straumann E, Naegeli B, Mury R, et al. Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock. Clin Res Cardiol. 2008;97(5):298–305.

Article  PubMed  CAS  Google Scholar 

Cuinet J, Garbagnati A, Rusca M, Yerly P, Schneider AG, Kirsch M, et al. Cardiogenic shock elicits acute inflammation, delayed eosinophilia, and depletion of immune cells in most severe cases. Sci Rep. 2020;10(1):7639.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kohsaka S, Menon V, Lowe AM, Lange M, Dzavik V, Sleeper LA, et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med. 2005;165(14):1643–50.

Article  PubMed  Google Scholar 

Pudil R, Krejsek J, Pidrman V, Gregor J, Tichý M, Bures J. Inflammatory response to acute myocardial infarction complicated by cardiogenic shock. Acta Medica (Hradec Kralove). 2001;44(4):149–51.

Article  PubMed  CAS  Google Scholar 

Jentzer JC, Bhat AG, Patlolla SH, Sinha SS, Miller PE, Lawler PR, et al. Concomitant sepsis diagnoses in acute myocardial Infarction-Cardiogenic shock: 15-Year National Temporal trends, management, and outcomes. Crit Care Explor. 2022;4(2):e0637.

PubMed  PubMed Central  Google Scholar 

van Diepen S, Vavalle JP, Newby LK, Clare R, Pieper KS, Ezekowitz JA, et al. The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction. Crit Care Med. 2013;41(9):2080–7.

Article  PubMed  Google Scholar 

Jentzer JC, Lawler PR, Diepen Sv, Henry TD, Menon V, Baran DA et al. Systemic Inflammatory Response Syndrome Is Associated With Increased Mortality Across the Spectrum of Shock Severity in Cardiac Intensive Care Patients. Circulation: Cardiovascular Quality and Outcomes. 2020;13(12):e006956.

Lim N, Dubois MJ, De Backer D, Vincent JL. Do all nonsurvivors of cardiogenic shock die with a low cardiac index? Chest. 2003;124(5):1885–91.

Article  PubMed  Google Scholar 

Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–50.

Article  PubMed  CAS  Google Scholar 

Dinarello CA. Historical insights into cytokines. Eur J Immunol. 2007;37(Suppl 1):S34–45.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. Circ Res. 2020;126(9):1260–80.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2016;138(4):984–1010.

Article  PubMed  CAS  Google Scholar 

Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990;265(3):621–36.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Garlanda C, Dinarello Charles A, Mantovani A. The Interleukin-1 family: back to the future. Immunity. 2013;39(6):1003–18.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Black S, Kushner I, Samols D. C-reactive protein**. J Biol Chem. 2004;279(47):48487–90.

Article  PubMed  CAS  Google Scholar 

Rose-John S. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int J Biol Sci. 2012;8(9):1237–47.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Selejan S, Pöss J, Walter F, Hohl M, Kaiser R, Kazakov A, et al. Ischaemia-induced up-regulation of Toll-like receptor 2 in Circulating monocytes in cardiogenic shock. Eur Heart J. 2012;33(9):1085–94.

Article  PubMed  CAS  Google Scholar 

Griffin JH, Fernández JA, Gale AJ, Mosnier LO. Activated protein C. J Thromb Haemost. 2007;5(Suppl 1):73–80.

Article  PubMed  CAS  Google Scholar 

Fellner B, Rohla M, Jarai R, Smetana P, Freynhofer MK, Egger F, et al. Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2017;6(4):348–58.

PubMed  Google Scholar 

Geppert A, Steiner A, Zorn G, Delle-Karth G, Koreny M, Haumer M, et al. Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6. Crit Care Med. 2002;30(9):1987–94.

Article  PubMed  CAS  Google Scholar 

van Diepen S, Newby LK, Lopes RD, Stebbins A, Hasselblad V, James S, et al. Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy. Int J Cardiol. 2013;168(3):2127–33.

Article  PubMed  Google Scholar 

van Diepen S, Alemayehu WG, Zheng Y, Theroux P, Newby LK, Mahaffey KW, et al. Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction. J Thromb Thrombolysis. 2016;42(3):376–85.

Article  PubMed  Google Scholar 

Kataja A, Tarvasmäki T, Lassus J, Sionis A, Mebazaa A, Pulkki K, et al. Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock - Insights from the cardshock study. Int J Cardiol. 2021;322:191–6.

Article  PubMed  Google Scholar 

Andrié RP, Becher UM, Frommold R, Tiyerili V, Schrickel JW, Nickenig G, et al. Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction. Crit Care. 2012;16(4):R152.

Article  PubMed